Literature DB >> 16771856

Natural killer cells prime the responsiveness of autologous CD4+ T cells to CTLA4-Ig and interleukin-10 mediated inhibition in an allogeneic dendritic cell-mixed lymphocyte reaction.

Ashley Newland1, Graeme Russ, Ravi Krishnan.   

Abstract

Cytotoxic T-lymphocyte antigen 4 immunoglobulin (CTLA4-Ig) and interleukin (IL)-10 are immunomodulatory molecules which target CD28 costimulation by acting either directly or indirectly on the CD80/86 receptors on dendritic cells (DCs). This study examined the effect of combined treatment with CTLA4-Ig and IL-10 on T-cell responsiveness in a dendritic cell-mixed lymphocyte reaction (DC-MLR). T cells derived from nylon wool enrichment (NWT cells) demonstrated 15% (P = 0.006) and 10% (P = 0.0015) inhibition of proliferation with suboptimal doses of IL-10 (5 ng/ml) and CTLA4-Ig (20 ng/ml), respectively. Combined treatment with both agents resulted in 38% inhibition (P = 0.004) of the MLR response compared with untreated controls. In contrast to NWT cells, which consisted of CD4+, CD8+ and CD56+ (NK) cells, purified CD4+ T cells were less responsive to immunomodulation by CTLA4-Ig and IL-10. Repletion of the CD4+ T cells with NK cells restored IL-10 and CTLA4-Ig mediated immunomodulation, suggesting a role for NK cells in the regulation of DC-T-cell interactions. The specific effect of NK cells on DC activation was demonstrated by CD80 up-regulation on DCs in the absence of T cells. However, in the absence of DCs, NK cells augmented the proliferation of autologous CD4+ T cells stimulated by anti-CD3 monoclonal antibody (mAb), which was blocked by CTLA4-Ig. It is proposed that, in the MLR, immunomodulation by suboptimal CTLA4-Ig and IL-10 is influenced by cellular interactions of NK cells with DCs and T cells involving DC lysis and costimulation. Thus, NK cells prime both DCs and T cells to low doses of CTLA4-Ig and IL-10 during alloimmune responses, providing evidence for the potential interaction between innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16771856      PMCID: PMC1782277          DOI: 10.1111/j.1365-2567.2006.02359.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice.

Authors:  S Maier; C Tertilt; N Chambron; K Gerauer; N Hüser; C D Heidecke; K Pfeffer
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  A molecular basis for T cell suppression by IL-10: CD28-associated IL-10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3-kinase binding.

Authors:  C A Akdis; A Joss; M Akdis; A Faith; K Blaser
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

3.  NK cells stimulate proliferation of T and NK cells through 2B4/CD48 interactions.

Authors:  Erika Assarsson; Taku Kambayashi; John D Schatzle; Sven O Cramer; Arne von Bonin; Peter E Jensen; Hans-Gustaf Ljunggren; Benedict J Chambers
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

4.  Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions.

Authors:  Alessandra Zingoni; Thierry Sornasse; Benjamin G Cocks; Yuetsu Tanaka; Angela Santoni; Lewis L Lanier
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

5.  Targeting of human dendritic cells by autologous NK cells.

Authors:  J L Wilson; L C Heffler; J Charo; A Scheynius; M T Bejarano; H G Ljunggren
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

6.  Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice.

Authors:  P T Coates; R Krishnan; S Kireta; J Johnston; G R Russ
Journal:  Gene Ther       Date:  2001-08       Impact factor: 5.250

7.  Ovine dendritic cells transduced with an adenoviral CTLA4eEGFP fusion protein construct induce hyporesponsiveness to allostimulation.

Authors:  Ashley Newland; Svjetlana Kireta; Graeme Russ; Ravi Krishnan
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

8.  Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10.

Authors:  Michael R Shurin; Zoya R Yurkovetsky; Irina L Tourkova; Levent Balkir; Galina V Shurin
Journal:  Int J Cancer       Date:  2002-09-01       Impact factor: 7.396

9.  Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.

Authors:  C Andrew Bonham; Lansha Peng; Xiaoyan Liang; Zongyou Chen; Lianfu Wang; Linlin Ma; Holger Hackstein; Paul D Robbins; Angus W Thomson; John J Fung; Shiguang Qian; Lina Lu
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.

Authors:  Diego Piccioli; Silverio Sbrana; Emiliano Melandri; Nicholas M Valiante
Journal:  J Exp Med       Date:  2002-02-04       Impact factor: 14.307

View more
  2 in total

1.  Early exposure of interferon-γ inhibits signal transducer and activator of transcription-6 signalling and nuclear factor κB activation in a short-term monocyte-derived dendritic cell culture promoting 'FAST' regulatory dendritic cells.

Authors:  D Rojas-Canales; R Krishnan; C F Jessup; P T Coates
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Differential Roles of Dendritic Cells in Expanding CD4 T Cells in Sepsis.

Authors:  Samuel Darkwah; Nodoka Nago; Michael G Appiah; Phyoe Kyawe Myint; Eiji Kawamoto; Motomu Shimaoka; Eun Jeong Park
Journal:  Biomedicines       Date:  2019-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.